According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.26. In 2022 the company made an earnings per share (EPS) of -$1.38 a decrease over its 2021 EPS that were of $3.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.15 | -16.99% |
2022 | -$1.38 | -143.5% |
2021 | $3.18 | -226.43% |
2020 | -$2.51 | -11.39% |
2019 | -$2.84 | -25.47% |
2018 | -$3.81 | -23.94% |
2017 | -$5.00 | 143.74% |
2016 | -$2.05 |